More than half of patients taking a higher dose of Rina-S had confirmed objective responses, including two complete responses ...

Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...

Amidst global market turbulence, Asian markets have shown resilience, with Japan's stock indices experiencing modest gains and China's markets buoyed by stimulus hopes. In such an environment, ...

Welcome to Show the Receipts, a series where we ask interesting people to share exactly how much it costs to get shit done.

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...

A TROP2-directed antibody-drug conjugate, DB-1305/BNT325, demonstrated durable activity in patients with previously treated ovarian cancer in a first-in-human trial. These results were presented at ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE: CTEV), previously MultiPlan, ...

On Tuesday, Merck & Co (NYSE: MRK) Inc. emerged victorious in a significant legal dispute concerning its Gardasil vaccine, which is designed to prevent cervical and other serious cancers. U.S.

Verastem's assets, Avutometinib and Defactinib, show promising results in treating KRAS-mutated LGSOC. Read why VSTM stock is a Hold.

Equities researchers at Wedbush issued their Q1 2026 earnings per share (EPS) estimates for Nuvation Bio in a report issued on Thursday, March 6th. Wedbush analyst D. Nierengarten forecasts that the ...